{"id":"NCT00195663","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis","officialTitle":"A Prospective Multi-Centre Randomised, Double-Blind, Active Comparator-Controlled, Parallel-Groups Study Comparing the Fully Human Monoclonal Anti-TNFÎ± Antibody Adalimumab Given Every Second Week With Methotrexate Given Weekly and the Combination of Adalimumab and Methotrexate Administered Over 2 Years in Patients With Early Rheumatoid Arthritis (PREMIER).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-12","primaryCompletion":"2004-04","completion":"2012-04","firstPosted":"2005-09-20","resultsPosted":"2010-02-25","lastUpdate":"2013-07-12"},"enrollment":799,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Early Rheumatoid Arthritis"],"interventions":[{"type":"BIOLOGICAL","name":"Adalimumab","otherNames":["ABT-D2E7","Humira"]},{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"BIOLOGICAL","name":"Adalimumab placebo","otherNames":[]},{"type":"DRUG","name":"Methotrexate placebo","otherNames":[]}],"arms":[{"label":"Adalimumab","type":"EXPERIMENTAL"},{"label":"Adalimumab + methotrexate","type":"EXPERIMENTAL"},{"label":"Methotrexate","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to assess the safety and efficacy of adalimumab in combination with methotrexate in patients with recent onset rheumatoid arthritis (RA), and to assess the long-term safety and maintenance of efficacy after treatment with adalimumab for up to 10 years.","primaryOutcome":{"measure":"Number of Participants Meeting American College of Rheumatology 50% (ACR50) Response Criteria at Week 52","timeFrame":"Baseline and 52 Weeks","effectByArm":[{"arm":"Methotrexate","deltaMin":118,"sd":null},{"arm":"Adalimumab","deltaMin":113,"sd":null},{"arm":"Adalimumab + Methotrexate","deltaMin":165,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":123,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Denmark","Finland","France","Germany","Ireland","Italy","Netherlands","Norway","Slovakia","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["31707982","30076156","29955381","29018564","28950430","27338778","25994819","25073879","24293583","24241487","22915617","22045836"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":47,"n":257},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Rheumatoid arthritis","Nausea"]}}